(Total Views: 730)
Posted On: 04/27/2020 7:26:30 PM
Post# of 148908
Just out of curiosity i listened the Interview of James West again and heard another name might you recognized ?
I think Nader says Lonza which could be this one (not 100% sure):
https://en.wikipedia.org/wiki/Lonza_Group
If this should come true we are up to something really big in a short time manner!
From Wikipedia:
Business operations
As of 2018, Lonza had twenty-four self-described major sites located in the United States, India, the Czech Republic, Belgium, Spain, China, France, South Africa, Switzerland, Singapore, Mexico, Japan, Brazil and the United Kingdom.[7] This site accounting shows significant changes from a 2016 self-description, which listed sixteen major sites.The presence in India was established in Genome Valley, where ground was broken in 2011.
In 2018, Lonza opened a 300,000 square feet (28,000 m2) facility in the United States in Pearland, Texas (a suburb of Houston). This is one of four sites which are focused on cell and gene therapy, the other three being in Portsmouth, New Hampshire; Geleen, Netherlands; and Singapore.
As of 2016, the company employed around 10,000 people,:22 across about 18 countries.:89 By 2018, employment was noted as 14,500 across 100 sites.
I think Nader says Lonza which could be this one (not 100% sure):
https://en.wikipedia.org/wiki/Lonza_Group
If this should come true we are up to something really big in a short time manner!
From Wikipedia:
Business operations
As of 2018, Lonza had twenty-four self-described major sites located in the United States, India, the Czech Republic, Belgium, Spain, China, France, South Africa, Switzerland, Singapore, Mexico, Japan, Brazil and the United Kingdom.[7] This site accounting shows significant changes from a 2016 self-description, which listed sixteen major sites.The presence in India was established in Genome Valley, where ground was broken in 2011.
In 2018, Lonza opened a 300,000 square feet (28,000 m2) facility in the United States in Pearland, Texas (a suburb of Houston). This is one of four sites which are focused on cell and gene therapy, the other three being in Portsmouth, New Hampshire; Geleen, Netherlands; and Singapore.
As of 2016, the company employed around 10,000 people,:22 across about 18 countries.:89 By 2018, employment was noted as 14,500 across 100 sites.
(3)
(0)Scroll down for more posts ▼
